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The estimates of prevalence of b-thalassemia in India
are grossly underestimated, as it is based on 0-5%
carrier frequency, while population surveys indicated
communities with as high frequency as 24%. The overall
carrier frequency distribution of b-thalassemia, is highly
heterogeneous with wide geographical foci of high risk
communities with 8% and above carrier frequency all
over the country. As of now, there is no mechanism to
evaluate whether the frequencies are increasing or
decreasing in the populations. Prenatal diagnosis and
prevention of births of b-thalassemia homozygotes is the
most preferred approach adopted in India. However, the
extent of distribution and the occurrence across various
stratification in the society with large component of
rural masses, it is difficult to assume that prenatal diag-
nosis alone can bring in ‘Zero’ b-thalassemia status in
India. Countries like Cyprus could achieve such status
where large scale population carrier screening programs
involving education and premarital counselling were
also effectively employed besides prenatal diagnosis. In
India, there is urgent need to initiate large scale popula-
tion carrier screening of high risk communities along
with education and awareness.
The extent of b-thalassemia distribution, identifying
high risk communities and geographical regions present-
ing a population design for carrier screening program in
India, will be presented.
Published: 21 January 2014
doi:10.1186/1755-8166-7-S1-I46
Cite this article as: Rao: Community genetics approaches in the
prevention of beta-thalassemia: towards achieving ‘Zero beta-
thalassemia’ status in India. Molecular Cytogenetics 2014 7(Suppl 1):I46.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submitCorrespondence: drraovr@yahoo.com
Department of Anthropology, University of Delhi, Delhi, India
Rao Molecular Cytogenetics 2014, 7(Suppl 1):I46
http://www.molecularcytogenetics.org/content/7/S1/I46
© 2014 Rao; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
